Miconazole%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520vaginal%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520pessary

# Miconazole Vaginal Pessary ## Overview Miconazole is an imidazole antifungal agent. The vaginal pessary formulation is used for the topical treatment of vulvovaginal candidiasis (yeast infections). ## Primary Indications Treatment of vulvovaginal candidiasis. ## Adult Dosing * **100 mg vaginal pessary:** Insert one pessary vaginally at bedtime for 7 consecutive days. * **200 mg vaginal pessary:** Insert one pessary vaginally at bedtime for 3 consecutive days. * **Single-dose 1200 mg vaginal suppository:** Insert one suppository vaginally as a single dose at bedtime. Dosing frequency and duration may vary based on product availability and clinical judgment. ## Pediatric Dosing Safety and efficacy in pediatric patients have not been established for miconazole vaginal pessaries. ## Dose Adjustments No dose adjustments are typically needed based on renal or hepatic impairment for topical vaginal use. ## Contraindications * Hypersensitivity to miconazole or any component of the formulation. ## Adverse Effects * **Common:** Vaginal burning, itching, irritation, pelvic cramps. * **Less Common:** Headache, rash, vulvar edema. ## Key Drug Interactions * **CYP3A4 Inhibitors:** Miconazole is a potent inhibitor of CYP3A4. Systemic absorption from vaginal administration is generally low, but caution is advised if co-administered with other medications metabolized by CYP3A4, particularly those with a narrow therapeutic index (e.g., warfarin, some statins, certain immunosuppressants). Close monitoring for increased drug levels and toxicity is recommended. ## Monitoring * Monitor for signs and symptoms of vulvovaginal candidiasis resolution. * Monitor for adverse effects. ## Clinical Pearls * The pessary should be inserted as high into the vagina as possible. * Treatment should be completed even if symptoms improve before the course is finished. * Sexual partners may require evaluation and treatment if symptomatic. * Avoid intercourse during treatment. * Consider an alternative if symptoms do not improve after completing therapy or if recurrent infections occur. *** **Disclaimer:** This information is intended for healthcare professionals. Always consult the official prescribing information and current clinical guidelines for the most up-to-date and complete drug information before making any clinical decisions.